Hiromi Tsuchiya Hidetaka Kioka Kentaro Ozu Tomohito Ohtani Osamu Yamaguchi Yoshikazu Yazaki Keiko Yamauchi-Takihara Yasushi Sakata
10.2169/internalmedicine.56.7822
Intern Med
2017;56(9):1061-1065.
hcv infection interferon therapy portopulmonary hypertension up-front combination therapy
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28458313/
Antiviral Agents / adverse effects Antiviral Agents / therapeutic use Hepatitis C, Chronic / drug therapy Hypertension, Pulmonary / drug therapy Hypertension, Pulmonary / etiology Interferons / adverse effects Interferons / therapeutic use
Antiviral Agents / adverse effects Antiviral Agents / therapeutic use Hepatitis C, Chronic / drug therapy Hypertension, Pulmonary / drug therapy Hypertension, Pulmonary / etiology Interferons / adverse effects Interferons / therapeutic use Case Reports Adult Female Humans Risk Factors Treatment Outcome Antiviral Agents Interferons
PMC5478568
28458313
Interferon Therapy Exacerbated Pulmonary Hypertension in a Patient with Hepatitis C Virus Infection: Pathogenic Interplay among Multiple Risk Factors
2017